Insider Transactions in Q1 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
923
+5.04%
|
-
|
|
Feb 15
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,186
-0.39%
|
$311,068
$38.39 P/Share
|
|
Feb 15
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,457
+0.88%
|
-
|
|
Feb 15
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-1.06%
|
$12,350
$38.39 P/Share
|
|
Feb 15
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+3.48%
|
-
|
|
Feb 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-0.74%
|
$9,842
$38.39 P/Share
|
|
Feb 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
738
+2.06%
|
-
|
|
Feb 15
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-0.24%
|
$21,850
$38.39 P/Share
|
|
Feb 15
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,661
+0.68%
|
-
|
|
Feb 15
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
707
-5.67%
|
$26,866
$38.39 P/Share
|
|
Feb 15
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,292
+9.39%
|
-
|
|
Feb 15
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-1.16%
|
$12,350
$38.39 P/Share
|
|
Feb 15
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+3.79%
|
-
|
|
Feb 15
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,228
-9.88%
|
$46,664
$38.39 P/Share
|
|
Feb 15
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,768
+18.22%
|
-
|
|
Feb 15
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
388
-2.79%
|
$14,744
$38.39 P/Share
|
|
Feb 15
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+7.36%
|
-
|
|
Feb 15
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-0.78%
|
$13,984
$38.39 P/Share
|
|
Feb 15
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+2.47%
|
-
|
|
Feb 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-0.47%
|
$23,636
$38.39 P/Share
|
|
Feb 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+1.5%
|
-
|
|
Feb 15
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,000
-1.37%
|
$38,000
$38.39 P/Share
|
|
Feb 15
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+2.46%
|
-
|
|
Feb 12
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
5,494
-4.01%
|
$208,772
$38.75 P/Share
|
|
Feb 12
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
28,883
-28.86%
|
$1,097,554
$38.65 P/Share
|
|
Feb 10
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,720
-2.4%
|
$255,360
$38.85 P/Share
|
|
Feb 10
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
16,195
+5.48%
|
-
|
|
Feb 10
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,806
-7.94%
|
$106,628
$38.85 P/Share
|
|
Feb 10
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Grant, award, or other acquisition
|
Direct |
7,197
+16.93%
|
-
|
|
Feb 10
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,901
-1.0%
|
$72,238
$38.85 P/Share
|
|
Feb 10
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
6,477
+3.31%
|
-
|
|
Feb 10
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-6.03%
|
$40,166
$38.85 P/Share
|
|
Feb 10
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Grant, award, or other acquisition
|
Direct |
3,598
+17.03%
|
-
|
|
Feb 10
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,193
-3.64%
|
$121,334
$38.85 P/Share
|
|
Feb 10
2021
|
Edward F Mackey EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,796
+10.95%
|
-
|
|
Feb 10
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,924
-1.52%
|
$1,213,112
$38.85 P/Share
|
|
Feb 10
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
71,981
+3.32%
|
-
|
|
Feb 10
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,268
-4.11%
|
$48,184
$38.85 P/Share
|
|
Feb 10
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,318
+12.27%
|
-
|
|
Feb 10
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
2,423
-1.74%
|
$92,074
$38.85 P/Share
|
|
Feb 10
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Grant, award, or other acquisition
|
Direct |
7,917
+5.37%
|
-
|
|
Feb 10
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
2,240
-0.93%
|
$85,120
$38.85 P/Share
|
|
Feb 10
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Grant, award, or other acquisition
|
Direct |
6,477
+2.61%
|
-
|
|
Feb 10
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
3,193
-24.84%
|
$121,334
$38.85 P/Share
|
|
Feb 10
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Grant, award, or other acquisition
|
Direct |
10,796
+45.65%
|
-
|
|
Feb 10
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,432
-3.01%
|
$54,416
$38.85 P/Share
|
|
Feb 10
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,678
+8.96%
|
-
|
|
Feb 10
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,268
-4.49%
|
$48,184
$38.85 P/Share
|
|
Feb 10
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,318
+13.26%
|
-
|
|
Feb 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,898
-3.75%
|
$148,124
$38.85 P/Share
|